記憶度
11問
28問
0問
0問
0問
アカウント登録して、解答結果を保存しよう
問題一覧
1
Excipient factors: Provides protection= prevents drug inactivation or degradation in the stomach
coatings
2
Into the artery
intraarterial
3
Process of dispensing different brand or unbranded drug product in place of the prescribed drug product
generic substitution
4
Drug is placed between cheeks and gums
buccal
5
Drugs susceptible to acid have reduced bioavailability
stability (stomach)
6
Rate limiting step in drug absorption
dissolution
7
Intramuscular is the only route that permits _________ volume of fluid
large
8
Excipient factors
lubricants, disintegrants, coatings
9
Process of dispensing pharmaceutical alternative for the prescribed drug product
pharmaceutical substitution
10
Tissue damage caused by subcutaneous injection
lipodystrophy
11
___________ particle size, ___________ surface area, ______________ dissolution rate
smaller, higher, faster
12
Bioavailability is the ____________ (relative amount) of drug that reaches the general circulation
fraction
13
States that ionizable compounds penetrate biological membranes primarily in the unionized form
ph partition theory
14
Difficult passage
hipe
15
Acidic drugs are best absorbed at ____________ ph
acidic/ low
16
Basic drugs are best absorbed at _______________ ph
basic/ high
17
Most important and most common parenteral parenteral administration route- into the peripheral vein
intravenous
18
Crystal forms or
polymorphs
19
Use of intraarterial
chemotherapy
20
Types of bioavailability
relative, absolute
21
Drug concentration at t=0 (drug- IV)
the cmax was achieved
22
The most common extravascular route * The drug undergoes complete first pass effect
oral
23
Process by which a solid drug substance is dissolved in a solvent over time
dissolution
24
What does polymorphism affect
stability, solubility, dissolution rate, etc
25
In Ph partition theory, despite their high degree of ionization (ph < pka), weak acids are highly absorbed in small intestine. Why?
large surface area, high contact time
26
Injected directly into the spine
intrathecal
27
Excipient factors: Less disintegrant = reduced dissolution
disintegrants
28
Trapezoidal rule compute the ___________ of each trapezoid
area
29
Other term for solvates
polymorphs
30
IV given in large dose dissolved in a vehicle
bolus
31
•safe and effective •pharma equivalents •they are bioequivalents •adequately labeled •compliant with cgmp guidelines
therapeutic equivalent
32
Ldf have _______________ rate of absorption than sdf
higher/ faster
33
The ______________ head groups of the phospholipids facing the protein layers and the __________________ tail groups aligned in the interior. -semi permeable membrane
hydrophilic, hydrophobic
34
Excipient factor that is hydrophobic = reduced dissolution
lubricants
35
auc measures the ______________ of bioavailability
extent
36
Example of therapeutic alternative
ranitidine, cemitidine
37
What rule is associated with auc
trapezoidal rule
38
Bioavailability is the _______ and _________ at which drug enters the ___________________________ thereby accessing the site of action
rate, extent, systemic circulation
39
Example of phrmaceutical alternative
tetracycline hcl and tetracycline po4
40
Two types of crystal forms
amorphous, crystalline
41
Same API Different salt, esters, complex, dosage forms
pharmaceutic alternative
42
Drug interaction is also known as
complexation
43
Numerical valve that reflect the needle diameter. The higher the number, the smaller the diameter
gauge
44
Balance between hydrophillic and lipophillic
partition coefficient
45
The onset time corresponds to time when
the MEC was first reached
46
Same api, salt, ester, complex, dosage form, quality Different shape, release mechanism, packaging,excipients, labeling
pharmaceutic equivalent
47
Refers to the comparison of bioavailabilities of different formulations, drug products, or batches of the same drug products -established when two drugs have similar BA
bioequivalence
48
The ability of the drug to be absorbed and used by the body
bioavailability
49
Regular shape More stable Slower dissolution rate
crystalline
50
Ratio of drug solubility (at equilibrium) in a non-aqueous solvent (n-octanol) to that in an aqueous solvent (water, ph 7.4 buffer solution)
partition coeffecient
51
Delivery of drug deep into the muscle is called ___________ effect
depot
52
Into the heart chamber - heart muscles and ventricles
intracardiac
53
Bioequivalence measure the ___________ ratio, ________ ratio, and ________ ratio
auc, cmax, tmax
54
Irregular shape Less stable Faster rate of dissolution
amorphous
55
Common sites of intramuscular injection
deltoid, buttocks, thighs
56
The duration of action is when
plasma drug concentration was within the therapeutic window
57
The tmax is when
the Cmax was achieved
58
auc measures the _________________ of drug in the body
quantity
59
Easy passage
luna
60
Dissolution rate is governed by
noyes whitney equation
61
Only takes effect at the site of administration
local effect
62
•comparison of non IV dosage forms •oral solution vs oral tablets
relative bioavailability
63
•non iv vs iv Standard: IV because it has 100%F
absolute bioavailability
64
Refers to any combination with the drug that results to altered properties
drug interaction
65
For a drug to exert its pharmacologic activity the plasma concentration should
within the therapeutic window
66
Arrangement of a drug substance in various molecular packing (crystal forms)
polymorphism
67
Placement of drug under the tongue *Bypass the first pass effect
sublingual
68
Same therapeutic category Different generic name
therapeutic alternative
69
2 layers of phospholipids between two surface layers of protein The hydrophilic head groups of the phospholipids facing the protein layers and the hydrophobic tail groups aligned in the interior.- semipermeable membrane
membrane physiology factor
70
In ph partition theory, the ionizable compounds penetrate biological membranes primarily in the ___________ forms
unionized
71
In drug substitution, substituted drug must have the same ______________, but differ in _____________
therapeutic moiety, manufacturer
72
Crystal formation after addition of solvent
polymorphs
73
Phenomenon of a drug metabolism whereby the concentration of the drug is greatly reduced before it reaches the systemic circulation
first pass effect
74
IV given over a period
infusion